Calypso Biotech Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Employees
  • 11
Employees
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $22.7M
Latest Deal Amount
  • Investors
  • 6

Calypso Biotech General Information

Description

Developer of monoclonal antibodies designed to provide treatment of immune pathologies with large unmet medical needs. The company's antibodies bind to and neutralize interleukin-15 (IL-15) which plays multiple roles in the immune system by controlling the homeostasis and activation of T, B, and NK, enabling patients suffering from severe gastro-intestinal diseases such as gastric and pancreatic cancer to begin treatment more quickly and result in a higher likelihood of successful treatment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Primary Office
  • Gustav Mahlerplein 102
  • 1082 MA Amsterdam
  • Netherlands
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Calypso Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series A) 20-Feb-2019 $22.7M 0000 Completed Generating Revenue
4. Seed Round 00.000 Completed Startup
3. Accelerator/Incubator 00.000 Completed Startup
2. Grant $185K $3.32M Completed Startup
1. Seed Round 04-Mar-2013 $3.32M $3.32M Completed Startup
To view Calypso Biotech’s complete valuation and funding history, request access »

Calypso Biotech Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of monoclonal antibodies designed to provide treatment of immune pathologies with large unmet medical needs. T
Biotechnology
Amsterdam, Netherlands
11 As of 2016
0000
00000000000 0000

00000000

pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit
0000 000000000
New York, NY
000 As of 0000
00000
000000 - 000 00000

00000000

ercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehe
0000000000000
Heidelberg, Germany
00 As of 0000
000.00
0000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Calypso Biotech Competitors (21)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Intercept(Biotechnology) Formerly VC-backed New York, NY 000 00000 000000 - 000 00000
00000000 Venture Capital-Backed Heidelberg, Germany 00 000.00 0000000000 000.00
0000 00000000000 Venture Capital-Backed Cambridge, MA 00 00000 00000000000 00000
000000000 Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
00 0000000 Venture Capital-Backed Copenhagen, Denmark 00 00000 00000000000 00000
You’re viewing 5 of 21 competitors. Get the full list »

Calypso Biotech Executive Team (4)

Name Title Board Seat Contact Info
Alain Vicari Ph.D Co-Founder, Chief Executive Officer & Board Member
Yolande Chvatchko Ph.D Co-Founder, Chief Scientific Officer & Board Member
Josefin-Beate Holz Chief Medical Officer
You’re viewing 3 of 4 executive team members. Get the full list »

Calypso Biotech Board Members (11)

Name Representing Role Since
Alain Vicari Ph.D Calypso Biotech Co-Founder, Chief Executive Officer & Board Member 000 0000
Alexandre LeBeaut MD Self Board Member 000 0000
Arthur Franken Gilde Healthcare Partners Board Member 000 0000
Bernard Coulie MD Self Co-Chairman 000 0000
Brian Feagan Calypso Biotech Chairman of Scientific Advisory Board 000 0000
You’re viewing 5 of 11 board members. Get the full list »

Calypso Biotech Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Calypso Biotech Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Gilde Healthcare Partners Venture Capital Minority 000 0000 000000 0
Inkef Capital Venture Capital Minority 000 0000 000000 0
Johnson & Johnson Innovation - JJDC Corporate Venture Capital Minority 000 0000 000000 0
M Ventures Corporate Venture Capital Minority 000 0000 000000 0
JLABS Accelerator/Incubator 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »